The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19. The committee that developed the draft framework was formed in July in response to a request from the National Institutes of Health and Centers for Disease Control and Prevention.

The committee defined the foundational principles, primary goal and criteria for determining an equitable allocation framework. For the initial period when vaccine demand exceeds supply, the committee recommends a four-phased approach guided by evidence to achieve the primary goal of maximizing societal benefit by reducing morbidity and mortality caused by the transmission of COVID-19. As the supply of vaccine increases, the framework says it will be incrementally phased in, so that some people or groups of people will receive it earlier than others. The discussion draft outlines the phases and rationale for prioritizing each group included in each phase.

The public comment period will be open from noon ET Sept. 1 until 11:59 p.m. ET Sept. 4. Commenters will be able to download and review the discussion draft before submitting a comment through a form on the NASEM website. The committee’s final report is expected early this fall.
 

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…